Youngjin Pharm

Youngjin Pharm is a prominent South Korean pharmaceutical company established in 1952 and a member of the KT&G Group. The company specializes in the development, manufacturing, and global distribution of a diverse portfolio, including antibiotics, respiratory treatments, and cardiovascular medications. Youngjin Pharm is recognized for its advanced manufacturing capabilities, particularly in cephalosporin antibiotics, and provides comprehensive contract manufacturing (CMO) services to global partners. Their research and development efforts are focused on innovative small molecules for chronic and rare diseases, with a notable program in mitochondrial medicine licensed to international partners. Publicly traded on the Korea Exchange, the company maintains a strong market presence through strategic exports and domestic sales. The company continues to expand its global footprint through partnerships and a robust pipeline of therapeutic candidates.